245 related articles for article (PubMed ID: 21789222)
1. Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion.
Dahiya N; Becker KG; Wood WH; Zhang Y; Morin PJ
PLoS One; 2011; 6(7):e22119. PubMed ID: 21789222
[TBL] [Abstract][Full Text] [Related]
2. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.
Rangel LB; Agarwal R; D'Souza T; Pizer ES; Alò PL; Lancaster WD; Gregoire L; Schwartz DR; Cho KR; Morin PJ
Clin Cancer Res; 2003 Jul; 9(7):2567-75. PubMed ID: 12855632
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.
Faddaoui A; Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Ghani K; Bachvarov D
Cell Cycle; 2017 Apr; 16(7):693-706. PubMed ID: 28278050
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines.
Ogawa M; Kojima T; Someya M; Nomura K; Takasawa A; Murata M; Tanaka S; Saito T; Sawada N
Histochem Cell Biol; 2012 Aug; 138(2):323-38. PubMed ID: 22544349
[TBL] [Abstract][Full Text] [Related]
5. Claudin-7 expression in human epithelial ovarian cancer.
Tassi RA; Bignotti E; Falchetti M; Ravanini M; Calza S; Ravaggi A; Bandiera E; Facchetti F; Pecorelli S; Santin AD
Int J Gynecol Cancer; 2008; 18(6):1262-71. PubMed ID: 18298564
[TBL] [Abstract][Full Text] [Related]
6. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.
Choi YL; Kim J; Kwon MJ; Choi JS; Kim TJ; Bae DS; Koh SS; In YH; Park YW; Kim SH; Ahn G; Shin YK
Histol Histopathol; 2007 Nov; 22(11):1185-95. PubMed ID: 17647191
[TBL] [Abstract][Full Text] [Related]
7. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity.
Agarwal R; D'Souza T; Morin PJ
Cancer Res; 2005 Aug; 65(16):7378-85. PubMed ID: 16103090
[TBL] [Abstract][Full Text] [Related]
8. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
9. High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma.
Kim CJ; Lee JW; Choi JJ; Choi HY; Park YA; Jeon HK; Sung CO; Song SY; Lee YY; Choi CH; Kim TJ; Lee JH; Kim BG; Bae DS
Eur J Cancer; 2011 Apr; 47(6):918-25. PubMed ID: 21134740
[TBL] [Abstract][Full Text] [Related]
10. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.
Shang X; Lin X; Alvarez E; Manorek G; Howell SB
Neoplasia; 2012 Oct; 14(10):974-85. PubMed ID: 23097631
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hepatocellular carcinoma invasion by suppression of claudin-10 in HLE cells.
Ip YC; Cheung ST; Lee YT; Ho JC; Fan ST
Mol Cancer Ther; 2007 Nov; 6(11):2858-67. PubMed ID: 18025272
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of claudin family proteins in mouse ovarian serous papillary epithelial adenoma in aging FSH receptor-deficient mutants.
Aravindakshan J; Chen X; Sairam MR
Neoplasia; 2006 Dec; 8(12):984-94. PubMed ID: 17217615
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12.
Gröne J; Weber B; Staub E; Heinze M; Klaman I; Pilarsky C; Hermann K; Castanos-Velez E; Röpcke S; Mann B; Rosenthal A; Buhr HJ
Int J Colorectal Dis; 2007 Jun; 22(6):651-9. PubMed ID: 17047970
[TBL] [Abstract][Full Text] [Related]
15. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.
Li H; Cai Q; Godwin AK; Zhang R
Mol Cancer Res; 2010 Dec; 8(12):1610-8. PubMed ID: 21115743
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases -2 expression in ovarian carcinoma.
Wang L; Jin X; Lin D; Liu Z; Zhang X; Lu Y; Liu Y; Wang M; Yang M; Li J; Quan C
Diagn Pathol; 2013 Nov; 8():190. PubMed ID: 24245968
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.
Heinzelmann-Schwarz VA; Gardiner-Garden M; Henshall SM; Scurry J; Scolyer RA; Davies MJ; Heinzelmann M; Kalish LH; Bali A; Kench JG; Edwards LS; Vanden Bergh PM; Hacker NF; Sutherland RL; O'Brien PM
Clin Cancer Res; 2004 Jul; 10(13):4427-36. PubMed ID: 15240533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]